Reports suggest increased risk of pulmonary toxicity in patients treated with cyclophosphamide and G-CSF.
Source: NLP:cyclophosphamide
2 interactions on record
Reports suggest increased risk of pulmonary toxicity in patients treated with cyclophosphamide and G-CSF.
Source: NLP:cyclophosphamide
Concomitant administration can prolong the duration of neutropenia. Do not initiate G-CSF until day 6 of topotecan therapy or 24 hours after completion of treatment.
Source: NLP:topotecan